31-Jan-2023 | Facts and Factors
According to Facts and Factors, the global seborrheic dermatitis market size was worth around USD 2.2 billion in 2021 and is predicted to grow to around USD 5 billion by 2030 with a compound annual growth rate (CAGR) of roughly 11.1% between 2022 and 2030.
Seborrheic dermatitis is a medical condition that usually affects the scalp of the affected person. It is a common skin condition and leads to inflamed skin, scaly patches along with dandruff. The condition typically occurs in the oily areas of the body like the side of the nose, face, eyelids, ears, chest, and eyebrows.
Browse the full “Seborrheic Dermatitis Market Size, Share, Growth Analysis Report By Route Of Administration (Parenteral, Topical, Oral, and Others), By Treatment (Antifungal, Anti-Inflammatory, Sulfur Products, and Others), By End-Users (Speciality Clinics, Hospitals, Homecare, and Others), By Dosage Form (Shampoos, Creams, Gels, Ointments, and Others), and By Region - Global and Regional Industry Insights, Overview, Comprehensive Analysis, Trends, Statistical Research, Market Intelligence, Historical Data and Forecast 2022 – 2030" report at https://www.fnfresearch.com/seborrheic-dermatitis-market
Seborrheic dermatitis is not contagious but it can be irritating and hamper the quality of life of the patients. With treatment, the condition might go away but there is no permanent cure as the chances of the condition coming back remain high. The patients may have to regularly use specially designed shampoos or other ointments to treat the condition. Patients living with seborrheic dermatitis generally refrain from trying new products as they may cause the infection to flare up or worsen.
The main treatment plan when treating adults requires the use of lotions, creams, and medicated shampoos. In mild situations, the condition can be treated with self-care habits and nonprescription products. There is no one answer as to the cause of the condition since various factors can influence the onset. Some of them include season change, stress, recovery from medical issues, and mental health conditions amongst others.
The global seborrheic dermatitis market is projected to grow owing to the increasing number of dermatological cases across the world. There are several reasons that can lead to the start of the disease and its intensity. For instance, as per studies, men are more prone to diseases as compared to women. In people who suffer from adult Hodkin’s lymphoma, human immunodeficiency virus (HIV), or have recently undergone an organ transplant, the chances of getting exposed to seborrheic dermatitis increase significantly.
In the USA alone, more than 121,678 are still waiting for organ donation and transplantation out of which 100,791 are in need of a functional kidney, as claimed by Statista. The global market may also be led by the increasing investments in the healthcare industry across the globe and especially in the studies of understanding the primary cause of seborrheic dermatitis and its effective cure.
The major factors that could impede the growth trajectory in the global market include the high cost of treatment and lack of awareness about the condition. Seborrheic dermatitis generally requires specifically designed medical treatment or drugs since generic medicines may not perform well. The shampoo brands that cater to the condition are sold separately and are generally expensive.
Affected populations in much of the world are unaware of the condition even if they are living with it. There is a significant lack of knowledge related to the understanding of medical cures, which means that the patients continue to live with seborrheic dermatitis with minimum to no treatment.
The increasing birth rate may provide expansion opportunities while the impact on quality of life could become a major challenge for market players.
Segmental Overview
The global seborrheic dermatitis market is segmented based on route of administration, treatment, end-users, dosage form, and region.
Based on treatment, the global market segments are antifungal, anti-inflammatory, sulfur products, and others. The global market was dominated by the antifungal segment in 2021 due to high product awareness. In most cases, doctors or medical professionals recommend topical antifungal creams to the patient to help them manage the condition.
The treatment is also coupled with anti-inflammatory products. Oral retinoids or antifungals are recommended only in the case of recalcitrant or serious cases. The most commonly used antifungal creams are ciclopirox olamine and ketoconazole. In mild or moderate cases, terbinafine 1% cream or ketoconazole 1% cream is used.
Based on end-users, the global market is divided into specialty clinics, hospitals, homecare, and others. The global market registered the highest growth in the specialty clinics segment. Dermatological cases are generally handled by specialists since they are well-equipped with resources to effectively treat the condition.
The growing number of dermatologists across the globe could help the segment to generate more revenue. The current number of members in the Indian Association of Dermatologists, Venereologists, and Leprologists is 12,500.
Regional Overview
North America is projected to register the highest growth in the global seborrheic dermatitis market due to the growing investments in research activities in the regional economies.
A report by Medical Dialogues in May 2022 claimed that the medical issue was linked to metabolic syndrome. Such information may prove beneficial for the medical community to diagnose the condition in its early stages and start the necessary treatment. Growth in Europe could be driven by the increasing geriatric population.
Germany and Italy are ranked amongst the top countries with the highest number of elderly people. Asia-Pacific is projected to register a significant CAGR driven by the growing investments in the pharmaceutical industry and the healthcare sector. The foreign direct investment in India reached USD 19.90 billion from April 2000 to June 2022.
Report Scope
Report Attribute |
Details |
Market Size in 2021 |
USD 2.2 Billion |
Projected Market Size in 2030 |
USD 5 Billion |
CAGR Growth Rate |
11.1% CAGR |
Base Year |
2021 |
Forecast Years |
2022-2030 |
Key Market Players |
Pfizer Inc., F. Hoffmann-La Roche Ltd., Eli Lilly and Company, Bayer AG, Abbott, Teva Pharmaceutical Industries Ltd, and others. |
Key Segment |
By Route Of Administration, Treatment, End-Users, Dosage Form, and Region |
Major Regions Covered |
North America, Europe, Asia Pacific, Latin America, and the Middle East &, Africa |
Purchase Options |
Request customized purchase options to meet your research needs. Explore purchase options |
Competitive Landscape
The global seborrheic dermatitis market is led by players like Pfizer Inc., F. Hoffmann-La Roche Ltd., Eli Lilly and Company, Bayer AG, Abbott, Teva Pharmaceutical Industries Ltd, and others
Recent Developments:
- In June 2022, Roflumilast foam 0.3%, developed by Arcutis Biotherapeutics’ showed positive results in phase 3 clinical trials
- In January 2022, the US Food and Drugs Administration approved CIBINQO® (abrocitinib) developed by Pfizer for dermatitis treatment in adults
The global seborrheic dermatitis market is segmented as follows:
By Route Of Administration
- Parenteral
- Topical
- Oral
- Others
By Treatment
- Antifungal
- Anti-Inflammatory
- Sulfur Products
- Others
By End-Users
- Speciality Clinics
- Hospitals
- Homecare
- Others
By Dosage Form
- Shampoos
- Creams
- Gels
- Ointments
- Others
By Region
- North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- South Africa
- Rest of the Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
About Us:
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Contact Us:
Facts & Factors
A 2108, Sargam,
Nanded City,
Sinhagad Road,
Pune 411041, India
USA: +1 (347) 690-0211
Email: [email protected]
Web: https://www.fnfresearch.com
